GSK asthma drug Nucala?s long-term study supports safety profile
 

GSK asthma drug Nucala?s long-term study supports safety profile
(Reuters) - GlaxoSmithKline Plc said on Saturday its asthma drug, Nucala, which is already approved in the United States and Europe, showed a similar safety profile in a long-term study compared with previous studies.


http://rc.feedsportal.com/r/24739378...14/rc/1/rc.img

http://rc.feedsportal.com/r/24739378...14/rc/2/rc.img

http://rc.feedsportal.com/r/24739378...14/rc/3/rc.img

http://da.feedsportal.com/r/24739378...d/sc/14/a2.img
http://adchoice.feedsportal.com/r/24.../sc/14/ach.imghttp://pi.feedsportal.com/r/24739378.../sc/14/a2t.imghttp://pi2.feedsportal.com/r/2473937...sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...Ek:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...Ek:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/DeDMqz7pVsc